Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis

被引:0
|
作者
Barrett, B. F. [1 ,5 ]
Wehmeyer, M. [2 ]
Kolb, J. [1 ]
Ostermann, T. [3 ]
Sappok, T. [4 ]
机构
[1] St Lukas Klin, Liebenau Kliniken, Liebenau, Germany
[2] Ludwig Maximilians Univ Munchen, Fac Psychol & Pedag, Dept Pedag & Rehabil, Munich, Germany
[3] Univ Witten Herdecke, Fac Hlth, Dept Psychol & Psychotherapy, Witten, Germany
[4] Bielefeld Univ, Univ Hosp OWL, Univ Clin People Neurodev Disorders, Mara, Bielefeld, Germany
[5] Liebenau Kliniken, St Lukas Klin, Siggenweilerstr 11, D-88074 Liebenau, Germany
关键词
antipsychotics; challenging behaviour; diagnostic assessment; psychiatric disorder; psychosis; scale of emotional development; CHALLENGING BEHAVIOR; PSYCHIATRIC-ASSESSMENT; MENTAL-ILLNESS; BASE-LINE; DIAGNOSIS; CHILDREN; INDIVIDUALS; PERSPECTIVE; AGGRESSION; PREVALENCE;
D O I
10.1111/jir.13136
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
BackgroundCompared with the general population, adults with an intellectual developmental disorder (IDD) are more likely to develop mental health problems and to receive high levels of psychotropic medication, particularly antipsychotics. The emotional development (ED) approach may help to better understand the nature of challenging behaviour (CB) and tailor treatment and support accordingly. The aim of this retrospective study was to investigate the impact of the ED approach on the prescription of psychotropic medication during inpatient psychiatric treatment.MethodsThe clinical data of 1758 patients were analysed within a retrospective study design over a period of 12 years. ED level was assessed (1) for the first time (INITIAL-SEO), (2) during a previous hospital stay (PAST-SEO) or (3) not at all (NO-SEO). The effects of the ED assessment and the respective intervention during the current admission on the number of psychotropics and the number and dosage of antipsychotics were analysed for the total sample, including those with CB, autism spectrum disorders and psychosis. Group differences were analysed by a chi-square test and a one-factorial analysis of variance. For analysing the impact of the application of the ED approach on psychotropic medication, a covariance model was applied. Changes between the subsamples were analysed by t-tests for dependent samples.ResultsThe ED approach had a significant impact on reducing the overall amount of psychotropic medication and the dosage of antipsychotics in all patients with IDD. These effects were mainly attributable to those showing CB. In patients with autism spectrum disorders, the developmental approach reduced the number of antipsychotics. No effects could be observed in patients with psychosis; in this subsample, both the number and dosage of antipsychotics increased.ConclusionsThe application of the ED approach in the current hospital stay reduced the number of psychotropic drugs and the number and dosage of antipsychotics, especially in those patients with IDD and CB, but also in those with autism spectrum disorders.
引用
收藏
页码:941 / 953
页数:13
相关论文
共 50 条
  • [1] Emotional Development in Adults with Autism and Intellectual Disabilities: A Retrospective, Clinical Analysis
    Sappok, Tanja
    Budczies, Jan
    Bolte, Sven
    Dziobek, Isabel
    Dosen, Anton
    Diefenbacher, Albert
    [J]. PLOS ONE, 2013, 8 (09):
  • [2] An Emotional Developmental Approach to Managing Medication in People With Intellectual Disabilities
    Barrett, Brian Fergus
    [J]. JOURNAL OF MENTAL HEALTH RESEARCH IN INTELLECTUAL DISABILITIES, 2017, 10 : 193 - 193
  • [3] ACCURACY OF PSYCHOTROPIC MEDICATION IN ADULTS WITH INTELLECTUAL DISABILITIES
    Hove, O.
    Biringer, E.
    Havik, O. E.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [4] Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities
    Schuetzwohl, M.
    Voss, E.
    Stiawa, M.
    Salize, H. -J.
    Puschner, B.
    Koch, A.
    [J]. NERVENARZT, 2017, 88 (11): : 1273 - 1280
  • [5] QUALITY OF PSYCHOTROPIC MEDICATION TREATMENT IN ADULTS WITH INTELLECTUAL DISABILITIES IN GERMANY
    Koch, A.
    Dobrindt, J.
    Schuetzwohl, M.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 697 - 697
  • [6] PREVALENCE OF PSYCHOTROPIC MEDICATION TREATMENT IN ADULTS WITH INTELLECTUAL DISABILITIES IN GERMANY
    Dobrindt, J.
    Koch, A.
    Schuetzwohl, M.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 696 - 696
  • [7] Medication use among adults with intellectual and developmental disabilities
    Cobigo, V.
    Ouellette-Kuntz, H.
    Lake, J. K.
    Wilton, A. S.
    Lunsky, Y.
    [J]. JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2014, 27 (04) : 320 - 320
  • [8] Prevalence and patterns of psychotropic medication treatment in adults with intellectual disabilities in germany
    Schuetzwohl, M.
    Koch, A.
    Dobrindt, J.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S410 - S411
  • [9] Psychotropic Medication in Intellectual and Developmental Disabilities: Patterns of Use and Recommendations for Monitoring Effects
    Maria G. Valdovinos
    [J]. Current Developmental Disorders Reports, 2019, 6 : 195 - 201
  • [10] Psychotropic Medication in Intellectual and Developmental Disabilities: Patterns of Use and Recommendations for Monitoring Effects
    Valdovinos, Maria G.
    [J]. CURRENT DEVELOPMENTAL DISORDERS REPORTS, 2019, 6 (04) : 195 - 201